Clostridioides difficile
Clostridioides difficile (C. difficile, formerly known as Clostridium difficile) is a Gram-positive, spore-forming, anaerobic bacteria that can cause severe infections in the human gastrointestinal system. C. difficile is the most common cause of healthcare-associated diarrhea and can lead to life-threatening colitis in severe cases.<ref>
Clostridioides difficile Infection(link). Centers for Disease Control and Prevention.
Accessed 2023-05-05.
</ref>


Epidemiology
C. difficile infections (CDIs) are responsible for significant morbidity and mortality, particularly in healthcare settings such as hospitals and long-term care facilities. The incidence of CDI has increased over the past few decades, with elderly patients and those with compromised immune systems being at the highest risk.<ref>Peniche, A. G., Savidge, T. C., & Dann, S. M.,
Clostridium difficile infection: A review of current and emerging therapies, Annals of Gastroenterology, 2016, Vol. 29(Issue: 2), pp. 147-154, Full text,</ref>
Pathogenesis
C. difficile produces two primary toxins, toxin A and toxin B, which cause inflammation and damage to the intestinal mucosa. The bacteria can form spores that are resistant to environmental conditions and are easily transmitted between individuals. CDI typically occurs when the normal gut flora is disrupted, often due to antibiotic use, which allows C. difficile to proliferate and produce toxins.<ref>Rupnik, M., Wilcox, M. H., & Gerding, D. N.,
Clostridium difficile Infection: An Overview of the Disease and Its Pathogenesis, Epidemiology and Interventions, Gut Microbes, 2010, Vol. 1(Issue: 4), pp. 234-242, Full text,</ref>
Clinical manifestations
Symptoms of CDI can range from mild diarrhea to severe colitis, toxic megacolon, and even death. Common symptoms include:
Watery diarrhea (occurring at least three times per day for two or more days) Abdominal pain or cramping Fever Loss of appetite Nausea Dehydration<ref>
Symptoms & Causes of C. difficile(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Accessed 2023-05-05.
</ref>
Diagnosis
Diagnosis of CDI typically involves stool testing for the presence of C. difficile toxins or the bacteria itself. Additional tests may include endoscopy or imaging studies, such as abdominal computed tomography (CT) scans, to assess the severity of the infection and potential complications.<ref>
Diagnosis of C. difficile(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Accessed 2023-05-05.
</ref>
Treatment
The primary treatment for CDI includes the discontinuation of the inciting antibiotic (if possible) and the initiation of a targeted antibiotic regimen, such as metronidazole, vancomycin, or fidaxomicin.<ref>McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., ... & Wilcox, M. H.,
Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clinical Infectious Diseases, 2018, Vol. 66(Issue: 7), pp. e1-e48, Full text,</ref> In severe or recurrent cases, fecal microbiota transplantation (FMT) may be considered to restore the normal gut flora and prevent further CDI recurrence.<ref>Gough, E., Shaikh, H., & Manges, A. R., Fecal microbiota transplantation for recurrent Clostridium difficile infection, Journal of Clinical Gastroenterology, 2014, Vol. 48(Issue: 3), pp. 241-247, Full text,</ref>
Prevention
Preventing the spread of C. difficile involves implementing strict infection control measures, such as hand hygiene, contact precautions, and environmental cleaning. In addition, judicious use of antibiotics is crucial in reducing the risk of CDI.<ref>
Prevention of C. difficile(link). National Institute of Diabetes and Digestive and Kidney Diseases.
Accessed 2023-05-05.
</ref>
See also
Antibiotic-associated diarrhea Infection control Probiotics Pseudomembranous colitis
References
<references group="" responsive="1"></references>
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


